These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 5992541)
1. [Kawa pyrone--a new kind of substance group of central muscle relaxants of the mephenesin type]. Meyer HJ; Kretzschmar R Klin Wochenschr; 1966 Aug; 44(15):902-3. PubMed ID: 5992541 [No Abstract] [Full Text] [Related]
2. [Comparative studies on the anticonvulsant activity of the pyrone compounds of Piper methysticum Forst]. Kretzschmar R; Meyer HJ Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):261-7. PubMed ID: 5807167 [No Abstract] [Full Text] [Related]
6. Central depressant and anticonvulsant properties of glycerol ethers isomeric with mephenesin. BERGER FM J Pharmacol Exp Ther; 1952 Aug; 105(4):450-7. PubMed ID: 14955775 [No Abstract] [Full Text] [Related]
7. [A drug from Polynesia with central nervous activity: Piper methysticum Forst ("kawa-kawa")]. REALDON E Gazz Med Ital; 1960 Jun; 119():231-3. PubMed ID: 14436715 [No Abstract] [Full Text] [Related]
8. Studies on Withania ashwagandha. (Part I): Effect of total extract on central nervous system and smooth muscles. MALHOTRA CL; DAS PK; DHALLA NS Indian J Physiol Pharmacol; 1960 Jan; 4():35-48. PubMed ID: 14420294 [No Abstract] [Full Text] [Related]
9. The analeptic action of 1-n-butylamino-3-p-toluidino-2-propanol (W181) in mephenesin paralysis. BERGER FM J Pharmacol Exp Ther; 1953 Feb; 107(2):250-7. PubMed ID: 13035663 [No Abstract] [Full Text] [Related]
10. [Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them]. Della Loggia R; Tubaro A; Redaelli C Riv Neurol; 1981; 51(5):297-310. PubMed ID: 6118937 [TBL] [Abstract][Full Text] [Related]
11. The central depressant properties of o-toloxypropyl carbamates. BERGER FM J Pharmacol Exp Ther; 1952 Apr; 104(4):468-73. PubMed ID: 14918069 [No Abstract] [Full Text] [Related]
12. [Superficial and deep EEG recordings of valerian-related drugs]. de Romanis F; Di Tondo U; Renda F; Sopranzi N Clin Ter; 1988 Jul; 126(2):101-8. PubMed ID: 2974376 [No Abstract] [Full Text] [Related]
13. Evaluation of muscle relaxants in post-tetanic fibrillation of the dog. Liu CT; Anderson K; Norman B; Rosenberg FJ Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):288-94. PubMed ID: 6064558 [No Abstract] [Full Text] [Related]
14. Site of action of 2, 2-diethyl-1,3-propanediol (prenderol) on the central nervous system. FUNDERBURK WH; UNNA KR J Pharmacol Exp Ther; 1953 Mar; 107(3):344-55. PubMed ID: 13035673 [No Abstract] [Full Text] [Related]
15. Central depressant effects of the extracts of magnolia cortex. Watanabe K; Goto Y; Yoshitomi K Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1700-8. PubMed ID: 4148314 [No Abstract] [Full Text] [Related]
16. [Simple methods for the pharmacologic differentiation of central muscle relaxants]. Hofrichter G; Roesch A; Roesch E; Schenk G Arzneimittelforschung; 1967 Feb; 17(2):242-5. PubMed ID: 5631491 [No Abstract] [Full Text] [Related]
17. [The inhibitory effect of Salvia miltriorrhiza Bge on the central nervous system (author's transl)]. Zhang HY; Ouyang R Yao Xue Xue Bao; 1979; 14(5):288-92. PubMed ID: 506729 [No Abstract] [Full Text] [Related]
18. Effect of an extract of Erioglossum edule on the central nervous system. Sattar MA; Gan EK; Loke SE; Mah KF; Wong WH J Ethnopharmacol; 1989 Apr; 25(2):217-20. PubMed ID: 2747256 [No Abstract] [Full Text] [Related]